“Alcon has a long legacy of advancing phaco and vitreoretinal technology for surgical ophthalmology. With UNITY VCS/CS, we are introducing more than a dozen innovations designed to transform surgical ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted 510(k) clearance to Alcon’s Unity combined vitreoretinal cataract system and stand-alone ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today revealed final data from its Vivity ® Registry Study, which monitored ...

Data on Alcon’s products across cataract, refractive, diagnostics and ocular health will be featured in presentations during the meeting Prospective analyses and studies demonstrate sustained ...

Acquisition of ALLY Robotic Cataract Laser Systems strengthens Alcon’s cataract equipment and technology portfolio Next generation technology will be expanded globally, improving the efficiency of ...

Aging is a natural part of life, and as we grow older, our bodies go through various changes. Our hair turns gray, our joints ache a bit more and our energy levels fluctuate. But one aspect of aging ...

Alcon, the multinational pharmaceuticals company specializing in eye care, has agreed a deal to acquire cataract laser surgery pioneer Lensar. The deal, valued at up to $430 million, will expand Alcon ...

Shares of eye care company Alcon AG (NYSE:ALC) are trading higher on Monday. The company has agreed to acquire LENSAR Inc (NASDAQ:LNSR), a firm recognized for its laser solutions in cataract surgery.

Please provide your email address to receive an email when new articles are posted on . Alcon will buy Lensar’s outstanding shares for $14 per share. The deal is expected to close in the second half ...